CALR and systemic lupus erythematosus: We found that the IRF5 SLE-risk haplotype was enriched even in these asymptomatic subjects with positive anti-Ro antibody, and that this enrichment was even greater (OR ~ 5) in those initially asymptomatic Ro-positive individuals who later developed SLE [75].